News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Mechanism controlling multiple sclerosis risk identified

June 20, 2018

Study results open new avenues for potential alternative treatments based on specific epigenetic modulation.
Learn more

Floodlight Open now enrolling in the U.S.

June 18, 2018

Floodlight Open is a new global study to collect and monitor anonymized patient data to gain a better understanding of MS disease progression
Learn more

Ocrevus may delay long-term disability in primary progressive MS

June 15, 2018

Genentech will be initiating two new global Phase IIIb studies that will evaluate the efficacy of Ocrevus in a broad range of people with progressive forms of MS.
Learn more

Drug may block death of brain cells in MS

June 14, 2018

Researchers were able to block the enzyme in the brain that is responsible for pyroptosis, using a drug that could potentially treat MS.
Learn more

Disappearing lesions may predict disability development

June 06, 2018

Researchers: Atrophied brain lesions were shown to be a more robust predictor of disability progression than the development of whole brain atrophy itself.
Learn more

Study: Compound produces beneficial inflammation, remyelination

May 31, 2018

Researchers report that indazole chloride is able to remyelinate damaged axons and alter the immune system.
Learn more

Researchers ID a DNA-binding factor that may trigger MS

May 18, 2018

Researchers identified a DNA-binding factor called TOX that might play a role in triggering MS.
Learn more

Study: Spinal fluid could be used to predict MS progression

May 15, 2018

Analysis of fluid in the spine could be used to predict future progression of multiple sclerosis.
Learn more

FDA approves Gilenya for pediatric relapsing MS

May 14, 2018

This expands the age range for Gilenya, which was previously approved for patients aged 18 years and older with RMS.
Learn more

Mechanism controlling multiple sclerosis risk identified

June 20, 2018

Study results open new avenues for potential alternative treatments based on specific epigenetic modulation.
Learn more

Floodlight Open now enrolling in the U.S.

June 18, 2018

Floodlight Open is a new global study to collect and monitor anonymized patient data to gain a better understanding of MS disease progression
Learn more

Ocrevus may delay long-term disability in primary progressive MS

June 15, 2018

Genentech will be initiating two new global Phase IIIb studies that will evaluate the efficacy of Ocrevus in a broad range of people with progressive forms of MS.
Learn more

Drug may block death of brain cells in MS

June 14, 2018

Researchers were able to block the enzyme in the brain that is responsible for pyroptosis, using a drug that could potentially treat MS.
Learn more

Disappearing lesions may predict disability development

June 06, 2018

Researchers: Atrophied brain lesions were shown to be a more robust predictor of disability progression than the development of whole brain atrophy itself.
Learn more

Study: Compound produces beneficial inflammation, remyelination

May 31, 2018

Researchers report that indazole chloride is able to remyelinate damaged axons and alter the immune system.
Learn more

Researchers ID a DNA-binding factor that may trigger MS

May 18, 2018

Researchers identified a DNA-binding factor called TOX that might play a role in triggering MS.
Learn more

Study: Spinal fluid could be used to predict MS progression

May 15, 2018

Analysis of fluid in the spine could be used to predict future progression of multiple sclerosis.
Learn more

FDA approves Gilenya for pediatric relapsing MS

May 14, 2018

This expands the age range for Gilenya, which was previously approved for patients aged 18 years and older with RMS.
Learn more

New study offers theory that MS may begin in brain

May 10, 2018

Findings suggest there may be something happening deeper and earlier that damages the myelin and then later triggers the immune attacks.
Learn more

Scientists find roadblock that stops myelin repair

May 09, 2018

A new study identifies a molecule that may be critical to the repair of myelin.
Learn more

FDA to hold public meeting on patient-focused drug development for chronic pain

May 07, 2018

The FDA is interested in hearing patients’ perspectives on chronic pain
Learn more

New study improves gait monitoring of MS treatments

May 04, 2018

Researchers have developed an algorithm that, when paired with wearable sensors, provides more informative and effective monitoring of the way people with MS walk
Learn more

New data says Ocrevus is effective and safe

April 26, 2018

New safety data consistent with Ocrevus’ favorable benefit-risk profile in both relapsing and primary progressive MS.
Learn more

Study: Sheep disease toxin may be linked to MS

April 24, 2018

A new study suggests that exposure to a toxin primarily found in sheep could be linked to the development of MS in humans.
Learn more

Epstein-Barr virus protein can 'switch on' risk genes for MS

April 18, 2018

Novel computational method shows a viral protein found in EBV-infected human cells may activate genes linked to autoimmunity risk.
Learn more

Finding could lead to new MS treatments

March 12, 2018

Researchers identified the overabundance of a specific protein in the brain of people who have MS.
Learn more

Eating fish may be tied to a reduced risk of MS

March 06, 2018

New findings suggest omega-3 fatty acids found in fish may be associated with lowering the risk of developing MS.
Learn more


Show More News